No Risk Alert Here: Before we dive into any analysis we simply note that Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) risk is neither elevated nor depressed. We’ll detail it below — but that’s the lede — the option market is in a holding period with an IV30 of 45.86% versus the IV30 of the S&P 500 at 10.08%. You might say that the post it note for Vertex Pharmaceuticals Incorporated would read, “holding pattern.” The annual high for Vertex Pharmaceuticals Incorporated IV30 is 58.68%.
To skip ahead and see if buying or selling options has been a winner in Vertex Pharmaceuticals Incorporated, you can go here: Getting serious about option trading.
This is a proprietary risk rating and risk alert system that looks forward for the next month — or really 30 days to be exact — and that includes weekends. The system is based on multiple interactions of data points, many of which come directly from the option market for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) . The creator of this model is Capital Market Laboratories (CMLviz.com).